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As a part of innate immune system, NK-cells are
first-line responders and they do not require antigen,
making them promising candidates for
immunotherapy.
Cancer cells downregulate MHC-I to evade T-cells,
which NK-cells can detect and destroy such cancer
cells by direct cytotoxicity.
Detecting whether the NK-cells have been delivered
to specific tumor sites is challenging. F-19 MRI can
be potentially used to detect the localization of NKcells in the targeted tumor.
Similarly, hyperpolarized C-13 MRI may be able to
detect metabolic response to immunotherapy in a
localized manner.
In this study, we aimed to detect the localization of
NK-cells in osteosarcoma which localized in lung of
mice and use CFT imaging to inform on the optimum
time to perform 19-F MRI after NK-cell
immunotherapy.

Hypothesis
We expect NK-cells to localize in lung tumor after
immunotherapy and we anticipate this will be
visible by CFT at multiple time-points.
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Intensity of NK cells in liver and lung tumor

3D image generated using vivo-quant by
combining all image slices from Xerra
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Figure 3. The intensity of NK-cells in liver and lung tumor at

Intensity of NK-cells was displayed using
vivo-quant software, and the resulting
intensities were quantified for
longitudinal comparison
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Figure 4. The ration of intensity of lung tumor vs. liver at
different time-points after NK-cells administration
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Figure 1. ROI in lung tumor and liver indicated
by orange region and blue region respectively
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Localization of F-19 NK cell was indicated by DiR in the
liver and lung tumor of all mice.
Besides liver and lungs, localization of some NK-cells was
observed in spinal cord and tail region in some mice.
The ratio of the intensity of NK-cells in lung tumor vs liver
was high for 4 hours and 8 hours after NK-cell
immunotherapy.

Results

NK cells were labelled with DIR, a membrane
label, that has an excitation spectrum of 750
nm and an emission spectrum of 782 nm.
These NK cells were Injected collaterally.
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The significant number of NK-cells found in the lung
osteosarcoma tumor suggests that NK-cell
immunotherapy maybe observed using this novel
theranostic imaging.
The ratio of NK-cells in lung tumor/liver was higher
during initial 8 hours, so 4-hour can be a good timing
for doing 19-F MRI.
The high intensity of fluorescence, further, suggests
that 19-F MRI can be used to detect the localization
of NK-cells in targeted organ(s) if 19-F imaging is
sensitive enough.
In order to verify the localization of NK-cells in-vivo,
more data are needed because tumor burden and
pathogenesis usually varies among different mice
and the sensitivity of the 19-F MRI experiment needs
to be optimized through hardware and better 19-F
tags.
Given this data, we form a new hypothesis for our
next set of measurements that NK-cells will be visible
with 19-F MRI at 4-8 hours after immunotherapy.
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